These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety. Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665 [TBL] [Abstract][Full Text] [Related]
11. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514 [TBL] [Abstract][Full Text] [Related]
12. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Lew EA; Pisegna JR; Starr JA; Soffer EF; Forsmark C; Modlin IM; Walsh JH; Beg M; Bochenek W; Metz DC Gastroenterology; 2000 Apr; 118(4):696-704. PubMed ID: 10734021 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients. Corleto V; Annibale B; D'Ambra G; Saggioro A; Ferrua B; Cassetta MR; Delle Fave G Aliment Pharmacol Ther; 1993 Apr; 7(2):167-73. PubMed ID: 8485270 [TBL] [Abstract][Full Text] [Related]
14. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Hirschowitz BI; Simmons J; Mohnen J Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001 [TBL] [Abstract][Full Text] [Related]
16. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Stewart CA; Termanini B; Sutliff VE; Serrano J; Yu F; Gibril F; Jensen RT Aliment Pharmacol Ther; 1998 Jan; 12(1):83-98. PubMed ID: 9692706 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome. Termanini B; Gibril F; Stewart CA; Weber HC; Jensen RT Aliment Pharmacol Ther; 1996 Feb; 10(1):61-71. PubMed ID: 8871445 [TBL] [Abstract][Full Text] [Related]
18. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection. Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182 [TBL] [Abstract][Full Text] [Related]
19. Omeprazole in the Zollinger-Ellison syndrome. Bardram L; Stadil F Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. Metz DC; Pisegna JR; Ringham GL; Feigenbaum K; Koviack PD; Maton PN; Gardner JD; Jensen RT Dig Dis Sci; 1993 Feb; 38(2):245-56. PubMed ID: 8425437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]